However, PT and aPTT elevations are less consistent in APL, and preserved levels of ATIII and protein C indicate antithrombotic checkpoints are still present, suggesting that other mechanisms also contribute to the elevated rates of thrombotic events [40,41,42]. This evidence concerns the gene F2 and acute promyelocytic leukemia.